The acquisition of AI-enabled technology from a top biohacking app positions Gaxos to potentially revolutionize its product offerings in the health and wellness sector. While the financial terms were not disclosed, the strategic move is likely to be viewed positively by investors, given the growing interest in AI and biohacking technologies. The lack of financial details makes the impact slightly uncertain, hence the confidence score is not at the maximum.